A Conversation on FemTech

​What is FemTech, you ask? It is a sub-sector of life sciences and technology that brings the spotlight to companies that are created to address medical conditions and issues that principally or differently impact the health and wellness of women, in addition to the funds that support them. We are at a turning point in the transformation of healthcare, and technological innovation in women’s health and wellness has never been stronger. Sage will discuss a number of hot topics and key FemTech market trends in the US and UK, and answer any questions you may have.

​About Sage

​Sage Revell is a partner in the Firm's International Corporate Practice Group and a member of the Firm's Global Life Sciences Practice Group. She advises on a wide range of corporate and commercial matters, including national and cross-border mergers and acquisitions, venture capital, private equity and corporate re-organizations. Sage represents companies from the start-up phase, early-stage and emerging-growth companies all the way through to exit, in addition to the investors who support them. Sage also serves as the Firm’s Diversity, Equity & Inclusion partner, alongside her counterpart Rod Moss.

​Sage is an advocate for women's health and wellness and leads the Firm's Femtech initiative in London and New York. Sage is a thought leader in the Femtech space, having been invited to present at the UCSF Rosenman Institute in San Francisco on the topic in May 2023, moderated a panel at the Decoding the Future of Women conference in London in June 2023, and co-presented on the 'Female Frontier – a Conversation on FemTech' at Startup Boston in September 2023 with RH Capital, to name a few.